Actos has been linked to Bladder Cancer.

Have you or a loved one been diagnosed with Bladder Cancer after using Actos, ACTOplus or ACTOplus met XR?

Find out for free if you have a legal claim.

Call: 1-877-704-8221

Text: 1-425-219-8808



Actos is Used to Treat Type Two Diabetes

Actos, manufactured by Takeda Pharmaceutical Co., was approved for use by the FDA in July of 1999. This medication, which contains the active ingredient pioglitazone hydrochloride, is a member of a class of medications known as thiazolidinediones and is used to treat type two diabetes. Since its introduction on the market Actos has been linked to numerous possible health risks.


Actos Usage Comes With Serious Risks

Since being introduced on to the market, Actos has been linked to serious side effects such as liver disease, kidney failure, cardiovascular issues and bladder cancer. One of the more significant health risks associated with Actos use is bladder cancer.
Bladder cancer is among the most common types of cancer diagnosed in the U.S. An average of one in 42 people will be diagnosed with bladder cancer in their lifetime. It is usually detected early, but it has a very high reoccurrence rate. There are five types of bladder cancer differentiated by which type of bladder cells the cancer has affected. The common symptoms of bladder cancer include:

√  Frequent or painful urination
√  Blood in the urine
√  Back Pain
√  Pelvic pain
√  Swelling in the legs

Over the years, numerous studies have shown evidence of a link between Actos and an increased risk of bladder cancer. A May 2011 study which utilized adverse event reports sent to the FDA over a five year period from 2004 to 2009 showed that one fifth of the bladder cancer reports from those taking a diabetes medicine were from patients taking Actos. The following month officials in France and Germany suspended sales of Actos in their respective countries. The suspension came after a study by the French Medicines Agent found that the risk of bladder cancer among Actos users is 22 percent higher than those taking other diabetes medications. The same month that France and Germany suspended sales of Actos, the FDA issued a safety warning announcing a risk of bladder cancer associated with the use of Actos for more than a year. This safety announcement was most likely the trigger to a wave of lawsuits filed against Takeda.

Call: 1-877-704-8221

Text: 425-219-8808

Lawsuits against the Makers of Actos

Since the link between Actos and bladder cancer became public knowledge, people from all over the country are turning to the legal system for compensation of their emotional, physical and financial damages. Thousands of lawsuits have been filed against Takeda Pharmaceutical Co. by individuals who suffered injuries after taking Actos. These lawsuits allege that Takeda failed to warn the public and health care providers about the risks associated with their product and further that they concealed data linking their product to certain serious health concerns. The number of federal lawsuits filed is so large that several thousand federal lawsuits have been assigned to a multidistrict litigation (MDL) in the U.S. District Court for the Western District of Louisiana.
In a recent article on there is word that Takeda may make an offer of $2.2 billion dollars to settle over 8,000 pending Actos lawsuits. While no settlement deal has officially been reached, talks of a potential settlement of such magnitude is evidence that Takeda may be worried about what the outcome of litigating all these cases may be.

What will an attorney cost me?

We represent our clients on a contingency fee basis. This means that if we do not win your claim their will be no obligation for you to pay us. The only way we are compensated for our services is if we are successful on your claim. A successful outcome on your claim could entitle you to damages for medical expenses, wage loss, pain and suffering, loss of enjoyment of life and loss of consortium. We would love to discuss your options further. Contact us today for a free consultation at (877) 704-8221. We are standing by 24/7, waiting to assist.

Do I have a case?

Sanders Phillips Grossman is currently accepting cases for people who have used Actos, ACTOplus, or ACTOplus met XR and were diagnosed with bladder cancer. If you or a loved one took one of these medications to treat diabetes and were later diagnosed with bladder cancer, we would like to discuss your legal options with you.

Call: 1-877-704-8221

Text: 425-219-8808


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>